Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2025-01-03T13:44:12.408Z Has data issue: false hasContentIssue false
  • English
  • Français

Controlled Trial of Prochlorperazine (“Stemetil”) in Schizophrenia

Published online by Cambridge University Press:  08 February 2018

South-east Region (Scotland) Therapeutic Trials Committee
Get access Rights & Permissions [Opens in a new window]

Extract

Since Delay, Deniker and Harl (1952) first reported favourably on the use of chlorpromazine in disturbed psychotic patients the extended use of pheno thiazines has contributed to the transformed atmosphere in mental hospital wards. There is still some doubt as to the precise mechanism of action of the phenothiazines. The blocking of arousal responses to afferent stimulation in animals following chlorpromazine has been fully demonstrated (Bradley and Hance, 1955, 1957). The production in man of a “parkinsoniansyndrome” by chlorpromazine and later phenothiazines has been taken as evidence of drug activity as a basal ganglion level (Kruse, 1957). More recent work suggests that chlorpromazine may act by depressing the collateral inflow into the reticular formation from the afferent pathways rather than the brain stem activating system itself (Key and Bradley, 1958).

Type
Original Articles
Information
Journal of Mental Science , Volume 107 , Issue 448 , May 1961 , pp. 514 - 522
Copyright
Copyright © Royal College of Psychiatrists, 1961 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bradley, P. B., and Hance, A. J., 1957.Google Scholar
Iidem, 1957, EEG Clin. Neurophysiol., 1957, 9, 191.Google Scholar
Boardman, R. H., Lomas, J., and Markowe, M., Lancet, 1956, ii, 487.Google Scholar
Collard, J. F., and Maggs, R., Brit. Med. J., 1958, 1, 1452.CrossRefGoogle Scholar
Delay, J., Deniker, P., and Harl, J. M., Ann. Med. Psychol., 1952, 110, 112.Google Scholar
Denham, J., J. Ment. Sci., 1958, 104, 1190.Google Scholar
Fish, F. J., Geron. Clin., 1959, 1, 127.Google Scholar
Foulds, G. A., J. Ment. Sci., 1958, 104, 259.Google Scholar
Frierson, B. D., J. Nerv. Menu Dis., 1958, 126, 585.Google Scholar
Galbraith, A. J., Hewat, J. K., and MacNamara, D., J. Ment. Sci., 1959, 105, 256.Google Scholar
Goldman, D., Amer. J. Med. Sci., 1958, 235, 67.Google Scholar
Houston, F., Brit. Med. J., 1956, i, 949.Google Scholar
Key, B. J., and Bradley, P. B., Nature, 1958, 182, 1517.Google Scholar
Kinross-Wright, V., Med. Clin. N. Amer., 1957, 41, 295.Google Scholar
King, P. D., and Weinberger, W., Amer. J. Psychiat., 1959, 115, 1026.Google Scholar
Kruse, W., Dis. Nerv. Syst., 1957, 18, 1.Google Scholar
Macdonald, R., and Shields Watts, T. P., Brit. Med. J., 1959, i, 549.Google Scholar
Milne, R. B., and Berliner, F., J. Ment. Sci., 1958, 104, 873.Google Scholar
Riesenman, F. R., and Pettit, M. B., Amer. J. Psychiat., 1959, 115, 1032.CrossRefGoogle Scholar
Sainsbury, P., and Lucas, C. J., Brit. Med. J., 1959, ii, 737.Google Scholar
Schneider, K., Klinische Psychopathologie, 1955. Stuttgart.Google Scholar
Vaughan, G. F., Leiberman, D. M., and Cook, L. C., Lancet, 1955, i, 1083.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.